UK markets close in 1 hour 15 minutes

Immunovia AB (publ) (IMMNOS.XC)

Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
4.3450-0.0950 (-2.14%)
As of 04:24PM BST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,211
1,575
1,145
844
362
-
Cost of revenue
5,643
6,682
4,211
-14,969
-40,020
-
Gross profit
-4,432
-5,107
-3,066
15,813
40,382
-
Operating expenses
Selling general and administrative
-
-
-
82,607
91,147
78,320
Total operating expenses
267,258
291,508
188,143
182,554
175,060
-
Operating income or loss
-271,690
-296,615
-191,209
-166,741
-134,678
-
Interest expense
-1,698
1,166
1,600
1,432
1,418
-
Income before tax
-260,727
-309,439
-168,092
-155,966
-146,033
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-260,727
-309,439
-168,092
-155,966
-146,033
-
Net income
-260,727
-309,439
-168,092
-155,966
-146,033
-
Net income available to common shareholders
-260,727
-309,439
-168,092
-155,966
-146,033
-
Basic EPS
-10.44
-7.38
-6.90
-6.39
-6.35
-
Diluted EPS
-10.44
-7.38
-6.90
-6.39
-6.35
-
Basic average shares
31,844
41,949
24,386
24,386
22,995
-
Diluted average shares
31,844
41,949
24,386
24,386
22,995
-